Structure-Based Discovery of HS34: A Highly Selective and Orally Bioavailable CDK9 Inhibitor for Triple-Negative Breast Cancer
1. 系统已在2026-03-20 14:01:03对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03822
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03822
其他信息:
出版社: American Chemical Society (ACS)
作者: Yaoguang Huang; Wenwu Liu; Xiaoyu Shi; Yixin Zhang; Xupeng Yang; Lianyu Tang; Shuning Sun; Qingchun Zhao; Jingming Jia; Anhua Wang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03822

